- Mots-clés > access to essential medicines
- Mots-clés > access to essential medicines and technologies for NCDs
- Mots-clés > access to opioid medications
- Mots-clés > measurement and reporting on access programs for NCDs
- Mots-clés > medicines policy
- Mots-clés > NCDs - cost-effective intervention strategies
- Mots-clés > noncommunicable diseases (NCDs) policies
- Mots-clés > public reporting - efforts to improve access to medicines globally
- Mots-clés > reporting system
(2018; 60 pages)
Boston, US: Boston University, 2018. Available at:
In 2017, more than 20 global R&D-based biopharmacetical companies, in partnership with the World Bank and the Union of International Cancer Control (UICC), launched Access Accelerated, an initiative that seeks to reduce barriers to prevention, treatment and care for non-communicable diseases (NCDs) in low- and middle-income countries. Members of Access Accelerated have committed to measuring their programs and reporting to the global health community. To facilitate these efforts, the Access Observatory team designed a new measurement framework, based on public health priorities, that serves as a common language for categorizing, understanding and comparing access programs. The Access Observatory (accessobservatory.org) is an online public repository of information on access programs, structured according to the measurement framework.
In Year One, 62 Access Accelerated programs operating in 103 countries were registered in the Access Observatory. Programs were geographically clustered in sub-Saharan Africa and Southeast Asia.
Year One of the Access Observatory has been one of development and learning, which has created a strong foundation for future success. Looking forward, there is a need for continued engagement on the part of the pharmaceutical industry as well as global health stakeholders. Companies and their partners should strive to design more effective programs and ensure accountability through transparency. The Access Observatory is a first-of-its-kind global platform for measurement and reporting on access programs. In securing an independent academic partner to measure and evaluate the progress of Access Accelerated, company CEOs and the Access Accelerated Secretariat clearly communicated to the global health community that measurement and, most importantly, the transparency of the measurement process are vital in order to share program learnings and be held accountable to their beneficiary populations and local stakeholders.